Concepedia

Yaming Li

YL

Statistics

Publications

60

Citations

5.5K

H-Index

33

Active since

2010

Affiliations

Qilu Hospital of Shandong University(Current)

Shandong University

Shandong First Medical University

Shandong Tumor Hospital

Shanghai Medical College of Fudan University

Yaming Li is an author at Qilu Hospital of Shandong University specializing in molecular oncology, oncology, and medicine.

ORCID

Publications per year

2010–2025

60

Publications

60

Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)

Jian Zhou, Hui‐Chuan Sun, Zheng Wang et al. · Liver Cancer · 2020 · 833 citations · Full text

, , +13

circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer

Yuting Sang, Bing Chen, Xiaojin Song et al. · Molecular Therapy · 2019 · 516 citations · Full text

, , +17

Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

Jian Zhou, Hui‐Chuan Sun, Zheng Wang et al. · Liver Cancer · 2023 · 452 citations · Full text

, , +12

RETRACTED ARTICLE: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis

Yiran Liang, Xiaojin Song, Yaming Li et al. · Molecular Cancer · 2020 · 396 citations · Full text

, , +17

LncRNA–CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA‐215

Xiaoli Kong, Yi Duan, Yuting Sang et al. · Journal of Cellular Physiology · 2018 · 301 citations

, , +17

1–5 of 60